Allergology International : Editorial Board

You are at: Home > Editorial Board

EDITOR-IN-CHIEF
Hirohisa SAITO, Tokyo, Japan

EDITORIAL BOARD
Cezmi A AKDIS, Davos, Switzerland
Koichiro ASANO, Tokyo, Japan
Thomas BIEBER, Bonn, Germany
Jean BOUSQUET, Montpellier, France
Shigeharu FUJIEDA, Fukui, Japan
Atsuki FUKUSHIMA, Kochi, Japan
Stephen J GALLI, Stanford, USA
Toshio HEIKE, Kyoto, Japan
Stephen T HOLGATE, Southampton, UK
Chein-Soo HONG, Seoul, Korea
Kenji IZUHARA, Saga, Japan
Tak H LEE, London, UK
Akio MORI, Kanagawa, Japan
Jae Won OH, Seoul, Korea
Yusei OHSHIMA, Fukui, Japan
Thomas AE PLATTS-MILLS, Charlottesville, USA
Johannes RING, Munich, Germany
Sergio ROMAGNANI, Florence, Italy
Takahiro SATOH, Tokyo, Japan
Robert SCHLEIMER, Chicago, USA
Shinji SHIMADA, Yamanashi, Japan
Kazuhiko TAKEUCHI, Mie, Japan
Jun TAMAOKI, Tokyo, Japan
Gary WONG, Hong Kong, China
Kohei YAMAUCHI, Iwate, Japan
Yukiyoshi YANAGIHARA, Kanagawa, Japan

ADVISORY COMMITTEE
K Frank AUSTEN, Boston, USA
John BIENENSTOCK, Hamilton, Canada
Alain DE WECK, Bern, Switzerland
Leonardo M FABBRI, Modena, Italy
Kimishige ISHIZAKA, Yamagata, Japan
SGO JOHANSSON, Stockholm, Sweden
A Barry KAY, London, UK
Tadamitsu KISHIMOTO, Osaka, Japan
Francois BM MICHEL, Montpellier, France
Minoru OKUDA, Tokyo, Japan
Mario RICCI, Florence, Italy
Albert L SHEFFER, Boston, USA
Reuben SIRAGANIAN, Bethesda, USA
Robert F TOWNLEY, Omaha, USA

From Editorial Board

Allergology International (AI) is the official journal of the Japanese Society of Allergology (JSA). It provides an international forum of basic and clinical research in allergology and immunology, especially aiming at advance excellence in research activities for allergology in Asia.

AI has been selected for coverage in Thomson Scientific products and services. Beginning with Vol.61, No.1, information on the contents of this publication is indexed in Science Citation Index Expanded, Current Contents^®/Clinical Medicine and others.

Also, the SCImago Journal (& Country) Rank (SJR http://www.scimagojr.com/index.php), which is a free online portal that includes the journal information developed from the one contained in the Scopus database (Elsevier B.V.) covering nearly 18,000 journals. Cites per Doc. (2y) measures the scientific impact of an average article published in the journal, it is computed using the same formula that Thomson Reuters' impact factor ^TM. AI has succeeded to maintain more than 2 of this index equivalent to the impact factor ^TM. Considering this, the impact factor ^TM of AI, which will appear soon, is also expected to be more than 2. As such, Allergology International will make a deeper and higher impact on allergists worldwide!

AI publishes original works in the fields of allergy, asthma, immunopathology, immunogenetics, immunopharmacology, mucosal immunity and immunology of infectious and connective tissue diseases.

Notes from Instruction for Authors

Please note some changes in Instruction for Authors. For example, according to the Declaration of Helsinki in Seoul 2008, we have revised some ethical issues. Clinical trials such as pharmacological interventions now should be preregistered to a public registry approved by WHO. Alternatively, such as for the previously designed studies, the authors should state why they did not preregister. Also, the authors who are not speaking native English are now requested to check and improve the manuscripts by language editing services before submission. Also, conflict of interest should be disclosed in the footnote when the article is published.